The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis.

NASH Western diet inhibitory T cell receptors liver natural killer cell receptor 2B4 non-alcoholic steatohepatitis programmed cell death protein 1

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 26 12 2018
accepted: 26 02 2019
entrez: 6 4 2019
pubmed: 6 4 2019
medline: 6 4 2019
Statut: epublish

Résumé

Infiltrating CD4 and CD8 T cells have been shown to worsen inflammatory liver damage in non-alcoholic steatohepatitis (NASH). Inhibitory T cell receptors such as the programmed cell death protein 1 (PD1) and the natural killer cell receptor 2B4 regulate the activity of CD4 and CD8 T cells and therefore play an important role in immune tolerance required in the liver. In this study, we investigated the expression profile of inhibitory T cell receptors on CD4 and CD8 T cells in a mouse model of NASH. Male B57BL/6J mice were fed a Western diet for 24 weeks. The expression levels of inhibitory receptors on the surface of intrahepatic and peripheral T cells were measured and correlated with markers of activation (CD107a, CD69, and CD44), metabolic disorder (serum triglycerides, serum cholesterol, γ-glutamyl transferase, hepatic triglycerides), inflammation (serum alanine aminotransferase and aspartate aminotransferase) and hepatic fibrosis (collagen 1A1, α-smooth muscle actin, hydroxyproline). Under Western diet, PD1 is exclusively upregulated on intrahepatic and peripheral CD8

Identifiants

pubmed: 30949049
doi: 10.3389/fphar.2019.00244
pmc: PMC6436071
doi:

Types de publication

Journal Article

Langues

eng

Pagination

244

Références

Clin Cancer Res. 2005 Apr 15;11(8):2947-53
pubmed: 15837746
J Biol Chem. 2006 Sep 15;281(37):26865-75
pubmed: 16798732
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G518-25
pubmed: 17023554
J Virol. 2007 Mar;81(6):2545-53
pubmed: 17182670
Cancer Immunol Immunother. 2007 Aug;56(8):1173-82
pubmed: 17186290
Clin Liver Dis. 2007 Feb;11(1):1-16, vii
pubmed: 17544968
J Virol. 2007 Sep;81(17):9249-58
pubmed: 17567698
J Hepatol. 2007 Oct;47(4):571-9
pubmed: 17644211
Hepatology. 2007 Nov;46(5):1519-29
pubmed: 17661402
Hepatology. 2007 Nov;46(5):1509-18
pubmed: 17705260
Liver Int. 2008 Aug;28(7):1026-33
pubmed: 18397235
Diabetes. 2009 Jan;58(1):125-33
pubmed: 18952835
Hepatology. 2009 Jun;49(6):1877-87
pubmed: 19291785
Nat Med. 2009 Aug;15(8):914-20
pubmed: 19633658
J Hepatol. 2010 Jan;52(1):130-2
pubmed: 19914729
Gastroenterology. 2010 Jul;139(1):323-34.e7
pubmed: 20347818
Hepatology. 2010 Dec;52(6):1934-47
pubmed: 21064032
Am J Physiol Gastrointest Liver Physiol. 2011 Mar;300(3):G433-41
pubmed: 21233280
Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60
pubmed: 21440669
Eur J Immunol. 2011 Oct;41(10):2966-76
pubmed: 21792877
Liver Transpl. 2012 Jan;18(1):29-37
pubmed: 21932374
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7049-54
pubmed: 22499789
PLoS One. 2012;7(11):e48738
pubmed: 23185273
Hepatology. 2013 Aug;58(2):589-602
pubmed: 23322710
Eur J Cancer. 2013 Jun;49(9):2233-42
pubmed: 23478000
PLoS One. 2013;8(3):e58417
pubmed: 23505504
AIDS. 2013 Sep 10;27(14):2191-200
pubmed: 23820090
PLoS One. 2013 Jul 02;8(7):e67709
pubmed: 23844072
J Gastroenterol Hepatol. 2014 Jan;29(1):110-5
pubmed: 23869988
J Leukoc Biol. 2013 Oct;94(4):813-23
pubmed: 23883516
Am J Physiol Gastrointest Liver Physiol. 2013 Oct 1;305(7):G483-95
pubmed: 23886860
Gastroenterology. 2014 Feb;146(2):550-61
pubmed: 24148617
Atherosclerosis. 2014 Apr;233(2):419-28
pubmed: 24530773
PLoS One. 2014 Feb 28;9(2):e89561
pubmed: 24586872
J Hepatol. 2014 Oct;61(4):883-90
pubmed: 24845607
Z Rheumatol. 2015 Apr;74(3):230-9
pubmed: 24942602
Sci Transl Med. 2014 Jun 25;6(242):242ra81
pubmed: 24964989
J Hepatol. 2015 Jan;62(1):31-40
pubmed: 25131771
Diabetes. 2015 Mar;64(3):867-75
pubmed: 25294945
Cancer Cell. 2014 Oct 13;26(4):549-64
pubmed: 25314080
Gastroenterology. 2015 Mar;148(3):590-602.e10
pubmed: 25479137
J Clin Exp Hepatol. 2012 Jun;2(2):135-44
pubmed: 25755422
Gene Ther. 2015 May;22(5):430-8
pubmed: 25786871
Cell Death Dis. 2015 Mar 19;6:e1694
pubmed: 25789969
Diabetologia. 2015 Jul;58(7):1579-86
pubmed: 25952479
Diabetes Care. 2015 Nov;38(11):e182-3
pubmed: 26310693
Lancet. 2016 Apr 9;387(10027):1540-50
pubmed: 26712084
Nat Commun. 2016 Jan 29;7:10582
pubmed: 26822383
Nature. 2016 Mar 10;531(7593):253-7
pubmed: 26934227
Lancet. 2016 May 7;387(10031):1909-20
pubmed: 26952546
Mol Med Rep. 2016 Aug;14(2):1107-16
pubmed: 27314219
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Nature. 2017 Nov 16;551(7680):340-345
pubmed: 29144460
Hepatology. 2018 Sep 4;:null
pubmed: 30179269
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102

Auteurs

Cordula Hansel (C)

Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Stephanie Erschfeld (S)

Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Maike Baues (M)

Institute for Experimental Molecular Imaging, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Twan Lammers (T)

Institute for Experimental Molecular Imaging, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Ralf Weiskirchen (R)

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy, and Clinical Chemistry (IFMPEGKC), University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Christian Trautwein (C)

Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Daniela C Kroy (DC)

Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Hannah K Drescher (HK)

Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Classifications MeSH